Opioids

A new Israeli technology used at Rambam Hospital helped free a man from dependence on painkillers

A breakthrough treatment was carried out at Rambam Medical Center, where specialists helped wean a man who had been taking about 130 painkiller pills a day in just 20 minutes.

A general view of the Rambam Hospital in Haifa, northern Israel, March 10, 2026.
US President Donald Trump shakes hands with Chinese President Xi Jinping as they hold a bilateral meeting at Gimhae International Airport, on the sidelines of the Asia-Pacific Economic Cooperation (APEC) summit, in Busan, South Korea, October 30, 2025.

Five arrested in China-US joint operation targeting drug trafficking

 PROF. PINHAS DANNON, chief psychiatrist of the Herzog Medical Center in Jerusalem and a leading expert on opioid addiction.

Finally recognizing the Israeli opioid disaster

 General view of the Ministry of Health building in Jerusalem October 17, 2021.

Health Ministry’s amendment for control on potentially deadly opioid prescriptions endorsed


Tufts University to remove Sackler name from buildings and programs

Family has come under fire for their central role in American opioid crisis

A sign stands at the edge of the campus of Tufts University in Medford, Massachusetts, U.S., November 27, 2017

‘Everyone Knows Somebody’: The opioid epidemic among Israel’s orthodox

Experts on ground see increase in number of deaths as misuse of fentanyl becomes more popular.

Orthodox Jews pray near Elimelech's grave, Lezajsk, Poland, 2018

Teva’s proposed settlement could cost drugmaker pennies on the dollar

Israel-based Teva is looking to reach a nationwide settlement over its role in selling opioid painkillers, together with drugmaker Johnson & Johnson and the three largest U.S. drug distributors.

A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem

Averting opioid trial, Teva, drug distributors reach last-gasp settlement

Under the agreement, Teva would donate Suboxone tablets up to the amount needed to meet the majority of the currently estimated US patient need over the next 10 years, valued at approximately $23b.

The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019

Opioid settlement talks fail with Teva, landmark trial expected Monday

After nearly 11 hours of negotiations, Pennsylvania Attorney General Josh Shapiro told reporters it was “profoundly disappointing” that local governments would not go along with a settlement.

A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem

Teva proposes $15 billion deal to settle opioid claims

The proposed settlement comes only days ahead of a landmark federal trial in Cleveland, Ohio, against the company and five drug distributors.

The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019

Sackler family reaped up to $13 billion from OxyContin maker

The wealthy Sacklers received the money from Purdue during an unspecified time frame, according to court documents and portions of a deposition filed in the drugmaker’s bankruptcy proceedings.

Bottles of prescription painkiller OxyContin, 40mg pills, made by Purdue Pharma L.D. sit on a shelf at a local pharmacy, in Provo, Utah, U.S.

Iran spends government money on cigarettes, uses over 2 tons of drugs daily

The subsidized exchange rate was meant to be spent on importing essential medical supplies, according to the deputy health minister.

Vendor smokes cigarette in Russian Bazaar - Jolfa - Iranian Azerbaijan - Iran

Oklahoma judge approves Teva's $85 million opioid settlement

The case is one of around 2,000 by state and local governments seeking to hold drugmakers responsible for an epidemic in the US.

A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem

Teva agreed to pay Oklahoma $85m to settle opioid claims

Claims against Teva focused on the branded opioid products Actiq and Fentora as well as generic painkillers it produced.

An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.